Adagio Medical Holdings, Inc. (ADGM) Stock Price & Analysis
Adagio Medical Holdings, Inc. (ADGM) closed at USD 0.1 on Thursday, October 15, 2026, up 15.73% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.1; the Oct 15, 2026 session ranged USD 0.08–0.11 on volume of 25,026,610 shares. Market capitalization is —, with a 52-week range of USD 0.08–1.69 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ADGM.md
Key facts (ADGM)
- Total return with dividends: 1Y -93.0% vs S&P 500 +18.1%; 5Y -98.7% vs S&P 500 +85.1%.
Total return (dividends reinvested) (ADGM)
| 1Y (from 2025-10-16) | 5Y (from 2024-07-29) | |
|---|---|---|
| Total return | -93.0% | -98.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -93.1% | -86.1% |
| Volatility (annualized) | 144.1% | 140.9% |
| Max drawdown | -94.5% (Apr 2026→Oct 2026) | -98.7% (Jul 2024→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:12 UTC)
| Price | USD 0.1 |
|---|---|
| Change | ▲ 15.73% (up) |
| Previous Close | USD 0.1 |
| Open | USD 0.1 |
| Day Range | USD 0.08 – 0.11 |
| 52-Week Range | USD 0.08 – 1.69 |
| Volume | 25,026,610 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ADGM)
Nexqual's technical model rates ADGM "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:12 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 24.24 (oversold) |
| vs SMA50 | Below (USD 0.44) |
| MACD | -0.1 (negative) |
Earnings (ADGM)
| EPS Estimate | USD -0.25 |
|---|---|
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.3 vs est -0.27 ▼ miss |
| 2026-03-31 | USD -0.31 vs est -0.29 ▼ miss |
| 2025-12-31 | USD -0.16 vs est -0.31 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:12 UTC.
Financials & Fundamentals (ADGM)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -657.76% |
| Current Ratio | 1.41 |
| Total Cash | $7.74M |
| Total Debt | $26.00M |
Source: Nexqual, October 16, 2026 at 05:12 UTC.
Ownership (ADGM)
| Insider Ownership | +0.95% |
|---|---|
| Institutional Ownership | +55.44% |
| Shares Outstanding | 27.44M |
| Float | 8.45M |
| Short % of Float | +10.66% |
Source: Nexqual, October 16, 2026 at 05:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMIX | Autonomix Medical, Inc. | USD 2.93 | ▼ 2.66% |
| TNMG | TNL Mediagene | USD 3.25 | ▼ 3.85% |
| AMOD | Alpha Modus Holdings, Inc. | USD 1.62 | ▼ 1.22% |
| GCTK | GlucoTrack, Inc. | USD 0.83 | ▼ 25.05% |
| SLXN | Silexion Therapeutics Corp | USD 0.19 | ▲ 7.39% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt